Skip to main content
SpringerLink
Log in

Cardiac Replacement Therapy

  • Chapter
Surgery

  • 780 Accesses

Abstract

The term cardiac replacement therapy until recently was limited to cardiac transplantation. Indeed, the term only evolved as significant innovations were made in the development and implementation of cardiac assist systems as well as xenotransplantation programs. Longterm implantable left-ventricular assist devices (LVAD) are currently in use throughout the world with increasing frequency. The current accepted role for these devices is as a bridge to transplantation; however, as experience is gained with use of these devices, other applications may be feasible and desirable.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Schocken DD, Arrieta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992; 20: 301–306.

    Article  PubMed  CAS  Google Scholar 

  2. Smith WM. Epidemiology of congestive heart failure. Am J Cardiol 1985; 55: 3A.

    CAS  Google Scholar 

  3. Funk D. Epidemiology of end-stage heart disease. In: Hogness R, VanAntwerp M, eds. The Artificial Heart: Prototypes, Policies, and Patients/Committee to Evaluate the Artificial Heart Program of the National Heart, Lung, and Blood Institute. Washington, DC: National Academy Press, 1991: 251–261.

    Google Scholar 

  4. Hosenpud JD, Bennett LE, Keck BM, et al. The Registry of the International Society for Heart and Lung Transplantation fifteenth official report-1998. J Heart Lung Transpl 1998; 17: 656–668.

    CAS  Google Scholar 

  5. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987, 16: 1429–1435.

    Google Scholar 

  6. Franciosa JA, Ziesche WM, Cohn JN. Survival in men with severe chronic left ventricular failure due to either coronary artery disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1983; 51: 831–836.

    Article  PubMed  CAS  Google Scholar 

  7. United Network for Organ Sharing (UNOS) 1996 Annual Report. UNOS, 1996.

    Google Scholar 

  8. DeBakey, ME. Left ventricular bypass pump for cardiac assistance: clinical experience. Am J Cardiol 1971; 27: 3–11.

    Article  PubMed  CAS  Google Scholar 

  9. Cooley DA, Liotta D, Hallman GL, et al. Orthotopic cardiac prosthesis for two staged cardiac replacement. Am J Cardiol 1969; 24: 723–730.

    Article  PubMed  CAS  Google Scholar 

  10. DeVries WC, Anderson JL, Joyce LD, et al. Clinical use of the total artificial heart. N Engl J Med 1984; 310: 273–278.

    Article  PubMed  CAS  Google Scholar 

  11. Oz MC, Goldstein DJ, Pepino P, et al. Selection scale predicts patients successfully receiving long-term, implantable left ventricular assist devices. Circulation 1995; 92 (suppl II):II169–II173.

    Article  Google Scholar 

  12. Thoratec VAD. System monograph of clinical results. 1998.

    Google Scholar 

  13. Farrar D. Atrial versus ventricular cannulation for bridge to transplantation with the Thoratec VAD system [presentation]. Cardiovascular Technology and Science meeting, 1992.

    Google Scholar 

  14. Miller PJ, Billich TJ, LaForge DH, et al. Initial clinical experience with a wearable controller for the Novacor left ventricular assist system. ASAIO J 1994; 40: M465 - M70.

    Article  PubMed  CAS  Google Scholar 

  15. I5. Oz MC, Dembitsky W. Personal communication and personal experience.

    Google Scholar 

  16. Pennington DG, McBride LR, Miller LW, Swartz MT. Eleven years’ experience with the Pierce-Donachy ventricular assist device. J Heart Lung Transplant 1994; 13: 803–810.

    PubMed  CAS  Google Scholar 

  17. Schmid C, Weyand M, Nabavi DG, et al. Cerebral and systemic embolization during left ventricular support with the Novacor N100 device. Ann Thorac Surg 1998; 65: 1703–1710.

    Article  PubMed  CAS  Google Scholar 

  18. McCarthy PM, Smedira NO, Vargo RL, et al. One hundred patients with the HeartMate left ventricular assist device: evolving concepts and technology. J Thorac Cardiovasc Surg 1998; 115: 904–912.

    Article  PubMed  CAS  Google Scholar 

  19. Sun B, Catanese K, Spanier T, et al. 100 long term implantable LVADs: the Columbia Presbyterian interim experience [accepted]. Ann Thorac Surg

    Google Scholar 

  20. McBride LR, Swartz MT, Reedy JE, Miller LW, Pennington DG. Device related infections in patients supported with mechanical circulatory support devices for greater than 30 days. ASAIO Trans 1991; 37: M258 - M259.

    PubMed  CAS  Google Scholar 

  21. Argenziano M, Catanese KA, Moazami N, et al. The influence of infection on survival and successful transplantation in patients with left ventricular assist devices. J Heart Lung Transplant 1997; 16: 822–831.

    PubMed  CAS  Google Scholar 

  22. Fischer SA, Trenholme GM, Costanzo MR, Piccione W. Infectious complications in left ventricular assist device recipients. Clin Infect Dis 1997; 24: 18–23.

    Article  PubMed  CAS  Google Scholar 

  23. Umana JP, Ewing D, Sun BC, et al. Use of pedicled muscle flaps successfully manages wound infections in implantable left ventricular assist device (LVADI patients with a low incidence of device endocarditis [abstract]. J Heart Lung Transplant 1997; 16: 93.

    Google Scholar 

  24. Prendergast TW, Todd BA, Beyer AJ III, et al. Management of left ventricular assist device infection with heart transplantation. Ann Thorac Surg 1997; 64: 142–147.

    Article  PubMed  CAS  Google Scholar 

  25. Massad MG, Cook DJ, Schmitt SK, et al. Factors influencing HLA sensitization in implantable LVAD recipients. Ann Thorac Surg 1997; 64: 1120–1125.

    Article  PubMed  CAS  Google Scholar 

  26. TCI Investigators and Users Meeting, 1997.

    Google Scholar 

  27. Spanier T, Oz M, Levin H, et al. Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices. J Thorac Cardiovasc Surg 1996; 112: 1090–1097.

    Article  PubMed  CAS  Google Scholar 

  28. Spanier T, Schmidt AM, Oz M. Cellular population of the textured-surface left ventricular assist devices leads to sustained activation of a procoagulant and proinflammatory systemic response [submitted].

    Google Scholar 

  29. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336: 1066–1071.

    Google Scholar 

  30. Oz MC. Personal communication.

    Google Scholar 

  31. Ankersent J, Tugulea S, Spanier T, Itescu S. Activation induced T cell death in LVAD recipients: an iatrogenic cause of immunodeficiency [submitted].

    Google Scholar 

  32. Tung T, Burke E, Itescu S. T cell apoptosis and B cell hyperreactivity in LVAD recipients: iatrogenic model of autoimmunity associated with HLA DR3 [submitted].

    Google Scholar 

  33. Muneretto C, Rabago G Jr, Pavie A, et al. Mechanical circulatory support as a bridge to transplantation: current status of total artificial hearts in 1989 and determinants of survival. J Cardiovasc Surg 1990; 31: 486–491.

    CAS  Google Scholar 

  34. Arabia FA, Copeland JG, Smith RG, et al. International experience with the CardioWest total artificial heart as a bridge to heart transplantation. Eur J Cardiothorac Surg 1997;(Suppl 111:S5–S10.)

    Google Scholar 

  35. Reemtsma K. Xenotransplantation: a brief history of clinical experiences: 1900–1965. In: Cooper DKC, Kemp E, Reemtsma K, White DJG, eds. Xenotransplantation. New York: Springer-Verlag, 1991: 10–12.

    Google Scholar 

  36. Reemtsma K. Renal heterotransplantation from nonhuman primates to man. Ann NY Acad Sci 1969; 162: 412–418.

    Article  PubMed  CAS  Google Scholar 

  37. Bailey LL. Nehlsen-Cannarella SL, Concepcion W, Jolley WB. Baboon-to-human cardiac xenotransplantation in a neonate. JAMA 1985; 254: 3321–3329.

    Article  PubMed  CAS  Google Scholar 

  38. Weyand M, Kececioglu D, Kehl HG, et al. Neonatal mechanical bridging to total orthotopic heart transplantation. Ann Thorac Surg 1998; 66: 519–522.

    Article  PubMed  CAS  Google Scholar 

  39. Herwig V, Severin M, Waldenberger FR, Konertz W. Medos/HIAassist system: first experiences with mechanical circulatory assist in infants and children. Int J Artif Organs 1997; 20: 692–694.

    PubMed  CAS  Google Scholar 

  40. Macha M, Litwak P, Yamazaki K, et al. Survival for up to six months in calves supported with an implantable axial flow ventricular assist device. ASAIO J 1997; 43: 311–315.

    PubMed  CAS  Google Scholar 

  41. Konishi H, Antaki JF, Litwak P, et al. Long-term animal survival with an implantable axial flow pump as a left ventricular assist device. Artif Organs 1996; 20: 124–127.

    Article  PubMed  CAS  Google Scholar 

  42. Westaby S, Katsumata T, Evans R, Pigott D, Taggart DP, Jarvik RK. The Jarvik 2000 Oxford system: increasing the scope of mechanical circulatory support. J Thorac Cardiovasc Surg 1997; 114: 467–474.

    Google Scholar 

  43. Kawahito K, Benkowski R, Ohtsubo S, Noon GP, Nose Y, DeBakey ME. Improved flow straighteners reduce thrombus in the NASA/DeBakey axial flow ventricular assist device. Artif Organs 1997; 21: 339–343.

    Article  PubMed  CAS  Google Scholar 

  44. Mizuguchi K, Damm G, Benkowsky R, et al. Development of an axial flow ventricular assist device: in vitro and in vivo evaluation. Artif Organs 1995; 19: 653–659.

    Article  PubMed  CAS  Google Scholar 

  45. Kawahito K, Damm G, Benkowski R, et al. Ex vivo phase 1 evaluation of the DeBakey/NASA axial flow ventricular assist device. Artif Organs 1996; 20: 47–52.

    Article  PubMed  CAS  Google Scholar 

  46. Goldstein DJ, Choudhri AF, Garfein E, et al. Experience with long term LVAD support: implications for permanent use. J Heart Lung Transpl 171, 11 63.

    Google Scholar 

  47. DeRose JJ, Argenziano M, Sun BC, Reemtsma K, Oz MC, Rose EA. Implantable left ventricular assist devices: an evolving longterm cardiac replacement therapy. Ann Surg 1997; 226:461–468; discussion 468–470.

    Article  PubMed  CAS  Google Scholar 

  48. Oz MC, Argenziano M, Catanese KA, et al. Bridge experience with long-term implantable left ventricular assist devices: are they an alternative to transplantation? Circulation 1997; 95: 1844–1852.

    Article  PubMed  CAS  Google Scholar 

  49. DeRose JJ Jr, Umana JP, Argenziano M, et al. Implantable left ventricular assist devices provide an excellent outpatient bridge to transplantation and recovery. J Am Coll Cardiol 1997; 30: 1773–1777.

    Article  PubMed  Google Scholar 

Download references

Authors
  1. Benjamin C. Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of California, San Francisco, USA

    Jeffrey A. Norton MD (Professor and Vice-Chairman of Surgery, Chief) (Professor and Vice-Chairman of Surgery, Chief)

  2. Surgical Service, San Francisco VA Medical Center, San Francisco, California, USA

    Jeffrey A. Norton MD (Professor and Vice-Chairman of Surgery, Chief) (Professor and Vice-Chairman of Surgery, Chief)

  3. Division of General Surgery, Duke University Medical Center, Durham, North Carolina, USA

    R. Randal Bollinger MD, PhD (Professor of Surgery, Professor of Immunology, Chief) (Professor of Surgery, Professor of Immunology, Chief)

  4. Division of Surgical Oncology, University of Michigan, Comprehensive Cancer Center, Ann Arbor, Michigan, USA

    Alfred E. Chang MD (Chief, Hugh Cabot Professor of Surgery) (Chief, Hugh Cabot Professor of Surgery)

  5. Department of Surgery, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA

    Stephen F. Lowry MD (Professor and Chairman) (Professor and Chairman)

  6. Division of General Surgery, University of California, San Francisco, San Francisco, California, USA

    Sean J. Mulvihill MD (Professor of Surgery, Chief) (Professor of Surgery, Chief)

  7. Karmanos Cancer Institute, Wayne State University, Harper Hospital, Detroit, Michigan, USA

    Harvey I. Pass MD (Professor of Surgery and Oncology, Chief of Thoracic Oncology) (Professor of Surgery and Oncology, Chief of Thoracic Oncology)

  8. Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri, USA

    Robert W. Thompson MD (Associate Professor of Surgery) (Associate Professor of Surgery)

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media New York

About this chapter

Cite this chapter

Sun, B.C. (2001). Cardiac Replacement Therapy. In: Norton, J.A., et al. Surgery. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-57282-1_70

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-57282-1_70

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-63239-6

  • Online ISBN: 978-3-642-57282-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation